Studies have shown that Syk inhibitors can inhibit proliferation and induce apoptosis in these kinase cells in MM, where inhibition of the p38 pathway has been shown to be one of the consequences of such treatment [71]. This evidence concerns the gene MAPK1 and Miyoshi myopathy.